News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Malin Life Sciences Holdings Ltd
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/07/2022 |
SC 13G/A
| Malin Life Sciences Holdings Ltd has filed a Schedule 13D for Immunocore Holdings plc |
| 08/10/2022 |
4
| Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Bought 2,150,000 shares
@ $3.5, valued at
$7.5M
|
|
| 02/10/2022 |
SC 13G/A
| Malin Life Sciences Holdings Ltd reports a 5.4% stake in Immunocore Holdings plc |
| 12/07/2021 |
4
| Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Bought 1,828 shares
@ $6.9, valued at
$12.6k
|
|
| 12/02/2021 |
4
| Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Bought 28,592 shares
@ $6.8494, valued at
$195.8k
Bought 18,365 shares
@ $6.8503, valued at
$125.8k
Bought 4,296 shares
@ $6.8786, valued at
$29.6k
|
|
| 11/29/2021 |
4
| Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Bought 1,054 shares
@ $6.8882, valued at
$7.3k
Bought 27,251 shares
@ $6.8068, valued at
$185.5k
Bought 11,057 shares
@ $6.8924, valued at
$76.2k
|
|
| 11/23/2021 |
4
| Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Bought 11,104 shares
@ $7.4433, valued at
$82.7k
Bought 14,625 shares
@ $6.7685, valued at
$99k
|
|
| 11/18/2021 |
4
| Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Bought 27,680 shares
@ $7.167, valued at
$198.4k
Bought 280,384 shares
@ $7.2109, valued at
$2M
Bought 71,312 shares
@ $7.1753, valued at
$511.7k
|
|
| 10/15/2021 |
SC 13G
| Malin Life Sciences Holdings Ltd reports a 5.4% stake in Immunocore Holdings plc |
| 02/03/2021 |
SC 13G
| Malin Life Sciences Holdings Ltd reports a 14.9% stake in Poseida Therapeutics, Inc. |
| 07/15/2020 |
4
| Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Converted 7,013,918 shares
@ $0
Converted 1,168,985 shares
@ $0
Converted 690,124 shares
@ $0
Converted 315,098 shares
@ $0
Converted 8,746,356 preferred shares
@ $0
Converted 1,457,725 preferred shares
@ $0
Converted 860,585 preferred shares
@ $0
Converted 392,927 preferred shares
@ $0 |
|
| 07/09/2020 |
3
| Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 3 on Poseida Therapeutics, Inc. |
| 07/02/2019 |
4
| Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 4 on Novan, Inc.|
Txns:
| Sold 17,800 shares
@ $2.69, valued at
$47.9k
Sold 913 shares
@ $2.74, valued at
$2.5k
Sold 6,287 shares
@ $2.75, valued at
$17.3k
|
|
| 09/28/2016 |
4
| Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 4 on Novan, Inc.|
Txns:
| Converted 1,823,485 shares
@ $0
Bought 800,000 shares
@ $11, valued at
$8.8M
Converted 1,823,485 options to buy
@ $0 |
|
| 09/20/2016 |
3
| Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 3 on Novan, Inc. |
|
|